| Product Code: ETC6757903 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Colombia import shipments of alpha-glucosidase inhibitors in 2024 saw significant contributions from top exporting countries such as the United States, Mexico, Germany, France, and Italy. Despite the strong presence of these key players, the market exhibited low concentration levels based on the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 11.84%, indicating a healthy expansion of the market. Additionally, the growth rate from 2023 to 2024 stood at 1.25%, suggesting a steady upward trend in demand for alpha-glucosidase inhibitors in Colombia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Alpha-Glucosidase Inhibitors Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Alpha-Glucosidase Inhibitors Market - Industry Life Cycle |
3.4 Colombia Alpha-Glucosidase Inhibitors Market - Porter's Five Forces |
3.5 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.6 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Colombia Alpha-Glucosidase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Colombia |
4.2.2 Growing awareness about the benefits of alpha-glucosidase inhibitors in managing diabetes |
4.2.3 Rise in healthcare expenditure and focus on improving diabetes management in the country |
4.3 Market Restraints |
4.3.1 High cost associated with alpha-glucosidase inhibitors |
4.3.2 Limited reimbursement policies for diabetes medications in Colombia |
4.3.3 Competition from alternative diabetes management therapies |
5 Colombia Alpha-Glucosidase Inhibitors Market Trends |
6 Colombia Alpha-Glucosidase Inhibitors Market, By Types |
6.1 Colombia Alpha-Glucosidase Inhibitors Market, By Drug class |
6.1.1 Overview and Analysis |
6.1.2 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Drug class, 2021- 2031F |
6.1.3 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Acarbose (Precose), 2021- 2031F |
6.1.4 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Miglitol (Glyset), 2021- 2031F |
6.1.5 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Voglibose, 2021- 2031F |
6.2 Colombia Alpha-Glucosidase Inhibitors Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.4 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3 Colombia Alpha-Glucosidase Inhibitors Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.3.3 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.4 Colombia Alpha-Glucosidase Inhibitors Market Revenues & Volume, By Specialty Diabetes Centers, 2021- 2031F |
7 Colombia Alpha-Glucosidase Inhibitors Market Import-Export Trade Statistics |
7.1 Colombia Alpha-Glucosidase Inhibitors Market Export to Major Countries |
7.2 Colombia Alpha-Glucosidase Inhibitors Market Imports from Major Countries |
8 Colombia Alpha-Glucosidase Inhibitors Market Key Performance Indicators |
8.1 Number of new diabetes cases diagnosed annually in Colombia |
8.2 Percentage increase in prescriptions of alpha-glucosidase inhibitors |
8.3 Patient adherence rate to alpha-glucosidase inhibitors therapy |
8.4 Number of healthcare providers trained on the benefits of alpha-glucosidase inhibitors |
8.5 Rate of diabetes-related complications among patients using alpha-glucosidase inhibitors |
9 Colombia Alpha-Glucosidase Inhibitors Market - Opportunity Assessment |
9.1 Colombia Alpha-Glucosidase Inhibitors Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.2 Colombia Alpha-Glucosidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Colombia Alpha-Glucosidase Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Colombia Alpha-Glucosidase Inhibitors Market - Competitive Landscape |
10.1 Colombia Alpha-Glucosidase Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Colombia Alpha-Glucosidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |